136 related articles for article (PubMed ID: 19223759)
1. [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].
Inari H; Chiba A; Inaba M; Ino H; Fukahori M; Yoshida A
Gan To Kagaku Ryoho; 2009 Feb; 36(2):333-5. PubMed ID: 19223759
[TBL] [Abstract][Full Text] [Related]
2. Individualized chemotherapy based on organ selectivity: a retrospective study of vinorelbine and capecitabine for patients with metastatic breast cancer.
Liu XH; Man YN; Cao R; Liu C; Wu XZ
Curr Med Res Opin; 2014 Jun; 30(6):1017-24. PubMed ID: 24528110
[TBL] [Abstract][Full Text] [Related]
3. Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.
Giotta F; Latorre A; Cramarossa A; Simone G; Florio C; Oliva S; Lorusso V
Tumori; 2013; 99(6):278e-81e. PubMed ID: 24503803
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer.
Chan A; Conte PF; Petruzelka L; Tubiana-Mathieu N; Ganju V; Llombart A; Espie M; Majois F; Gil MG; Vaissiere N; Villanova G
Anticancer Res; 2013 Jun; 33(6):2657-64. PubMed ID: 23749924
[TBL] [Abstract][Full Text] [Related]
5. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of the capecitabine in patients with breast cancer with liver metastasis].
Gasanzade DA; Zeĭnalov RS; Musaev IN
Georgian Med News; 2009; (172-173):13-6. PubMed ID: 19644181
[TBL] [Abstract][Full Text] [Related]
7. [Two advanced/recurrent breast cancer cases effectively treated by trastuzumab/capecitabine combination therapy].
Inoue S; Inoue M; Takahashi H; Inoue A; Kunitomo K; Fujii H
Gan To Kagaku Ryoho; 2008 Feb; 35(2):319-22. PubMed ID: 18281774
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.
Di Seri M; De Sanctis R; Quadrini S; Adua D; Stumbo L; Del Signore E; Gori B; Grassi P; Basile ML; Longo F
J Chemother; 2011 Apr; 23(2):110-3. PubMed ID: 21571629
[TBL] [Abstract][Full Text] [Related]
9. [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
Umeda T; Abe H; Cho H; Shimizu T; Mori T; Kubota Y; Kawai Y; Tanaka M; Kurumi Y; Tani T
Gan To Kagaku Ryoho; 2010 Apr; 37(4):687-9. PubMed ID: 20414027
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine and vinorelbine in metastatic breast cancer.
Chan A; Verrill M
Eur J Cancer; 2009 Sep; 45(13):2253-65. PubMed ID: 19464166
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R
Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418
[TBL] [Abstract][Full Text] [Related]
12. [A patient with axillary node metastasis from breast cancer who responded to trastuzumab/capecitabine combination therapy].
Tokugawa T; Kobayashi A; Matsuyama T; Imai S; Koyama H
Gan To Kagaku Ryoho; 2009 Mar; 36(3):467-9. PubMed ID: 19295273
[TBL] [Abstract][Full Text] [Related]
13. A three-arm randomized phase II study of oral vinorelbine plus capecitabine versus oral vinorelbine and capecitabine in sequence versus docetaxel plus capecitabine in patients with metastatic breast cancer previously treated with anthracyclines.
Campone M; Dobrovolskaya N; Tjulandin S; Chen SC; Fourie S; Mefti F; Konstantinova M; Lefresne F; Meheust N; Jassem J
Breast J; 2013; 19(3):240-9. PubMed ID: 23528159
[TBL] [Abstract][Full Text] [Related]
14. [A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)].
Hino N; Ikushima Y; Tsuyuguchi M; Sohnaka Y; Wada D; Yamasaki S; Miyake H; Ogasawara T; Yamamoto Y; Ohura R
Gan To Kagaku Ryoho; 2008 May; 35(5):809-12. PubMed ID: 18487918
[TBL] [Abstract][Full Text] [Related]
15. [A case of triple negative recurrent breast cancer successfully treated with capecitabine+docetaxel combination chemotherapy].
Hachisuka Y; Kamei Y; Umeoka T; Kimura M; Uomoto M; Hatano H; Johira H; Yunoki S; Kawata N; Watanabe R; Ohmori K; Miyata N
Gan To Kagaku Ryoho; 2008 Mar; 35(3):475-8. PubMed ID: 18347398
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).
Hess D; Koberle D; Thurlimann B; Pagani O; Schonenberger A; Mattmann S; Rochlitz C; Rauch D; Schuller JC; Ballabeni P; Ribi K;
Oncology; 2007; 73(3-4):228-37. PubMed ID: 18424887
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.
Morohashi S; Odagiri H; Morohashi H; Kimura Y; Sasaki M
Breast Cancer; 2007; 14(3):297-301. PubMed ID: 17690508
[TBL] [Abstract][Full Text] [Related]
18. All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer.
Tawfik H; Rostom Y; Elghazaly H
Cancer Chemother Pharmacol; 2013 Apr; 71(4):913-9. PubMed ID: 23344713
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
20. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
Huang H; Jiang Z; Wang T; Zhang S; Bian L; Cao Y; Wu S; Song S
Anticancer Drugs; 2012 Aug; 23(7):718-23. PubMed ID: 22739713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
